CD19 Molecule (CD19) (C-Term) Peptide
CD19
Reactivité: Humain
Hôte: Synthetic
BP, WB
N° du produit ABIN5512796
Aperçu rapide pour CD19 Molecule (CD19) (C-Term) Peptide (ABIN5512796)
Antigène
CD19
(CD19 Molecule (CD19))
Origine
Humain
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB)
-
-
Protein Region
- C-Term
-
Séquence
- RGILYAAPQL RSIRGQPGPN HEEDADSYEN MDNPDGPDPA WGGGGRMGTW
-
Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-CD19 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Stock
- -20 °C
-
Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CD19 (CD19 Molecule (CD19))
-
Sujet
-
Lymphocytes proliferate and differentiate in response to various concentrations of different antigens. The ability of the B cell to respond in a specific, yet sensitive manner to the various antigens is achieved with the use of low-affinity antigen receptors. This gene encodes a cell surface molecule which assembles with the antigen receptor of B lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation.
Alias Symbols: B4, CVID3
Protein Size: 557 -
ID gène
- 930
-
NCBI Accession
- NM_001178098, NP_001171569
Antigène
-
Vous êtes ici:
